Reactivities of the Front Pocket N-Terminal Cap Cysteines in Human Kinases

被引:18
|
作者
Liu, Ruibin [1 ]
Zhan, Shaoqi [1 ]
Che, Ye [2 ]
Shen, Jana [1 ]
机构
[1] Univ Maryland, Dept Pharmaceut Sci, Sch Pharm, Baltimore, MD 21201 USA
[2] Pfizer Worldwide Res & Dev, Discovery Sci, Groton, CT 06340 USA
基金
美国国家卫生研究院;
关键词
FACTOR RECEPTOR EGFR; IRREVERSIBLE INHIBITORS; COVALENT INHIBITORS; CRYSTAL-STRUCTURE; ALLOSTERIC ACTIVATION; PROTEIN-KINASE; DISCOVERY; FAMILY; THIOLS; DOMAIN;
D O I
10.1021/acs.jmedchem.1c01186
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The front pocket ( FP) N-terminal cap (Ncap) cysteine is the most popular site of covalent modification in kinases. A long-standing hypothesis associates the Ncap position with cysteine hyper-reactivity; however, traditional computational predictions suggest that the FP Ncap cysteines are predominantly unreactive. Here we applied the state-of-the- art continuous constant pH molecular dynamics (CpHMD) to test the Ncap hypothesis. Simulations found that the Ncap cysteines of BTK/BMX/TEC/ITK/TXK, JAK3, and MKK7 are reactive to varying degrees; however, those of BLK and EGFR/ERBB2/ERBB4 possessing a Ncap+3 aspartate are unreactive. Analysis suggested that hydrogen bonding and electrostatic interactions drive the reactivity, and their absence renders the Ncap cysteine unreactive. To further test the Ncap hypothesis, we examined the FP Ncap+2 cysteines in JNK1/JNK2/JNK3 and CASK. Our work offers a systematic understanding of the cysteine structure-reactivity relationship and illustrates the use of CpHMD to differentiate cysteines toward the design of targeted covalent inhibitors with reduced chemical reactivities.
引用
收藏
页码:1525 / 1535
页数:11
相关论文
共 50 条
  • [1] Selective Derivatization of N-Terminal Cysteines Using Cyclopentenediones
    Brun, Omar
    Agramunt, Jordi
    Raich, Lluis
    Rovira, Carme
    Pedroso, Enrique
    Grandas, Anna
    [J]. ORGANIC LETTERS, 2016, 18 (19) : 4836 - 4839
  • [2] Chemoselective Ligation of Peptide Phenyl Esters with N-Terminal Cysteines
    Fang, Ge-Min
    Cui, Hong-Kui
    Zheng, Ji-Shen
    Liu, Lei
    [J]. CHEMBIOCHEM, 2010, 11 (08) : 1061 - 1065
  • [3] Role of the c-Jun N-terminal kinases in human epidermal neoplasia
    Harris, R. N.
    Tao, S.
    Fox, A.
    Jin, Y.
    Zhang, J. Y.
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2007, 127 : S100 - S100
  • [4] Activation of c-Jun N-terminal kinases in human monocytic cells
    Thomas, GW
    Heasley, LE
    Dreskin, SC
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2000, 105 (01) : S158 - S158
  • [5] Stabilization of N-terminal cysteines in HPLCHRMS quality control of peptide pools
    Kreuzer, Oliver J.
    Weller, Michael G.
    Bosc-Bierne, Gaby
    [J]. JOURNAL OF IMMUNOLOGY, 2023, 210 (01):
  • [6] Analysis of pharmacologic inhibitors of Jun N-terminal kinases
    Murray, BW
    Bennett, BL
    Sasaki, DT
    [J]. REGULATORS AND EFFECTORS OF SMALL GTPASES, PT F, RAS FAMILY I, 2001, 332 : 432 - 452
  • [7] THE ROLE OF CONSERVED CYSTEINES IN THE N-TERMINAL DOMAIN OF THE FILAMENTOUS PHAGE ADSORPTION PROTEIN
    HEINHOLD, S
    BROSS, P
    RASCHED, I
    [J]. BIOLOGICAL CHEMISTRY HOPPE-SEYLER, 1990, 371 (09): : 791 - 791
  • [8] The Jun N-terminal kinases are important for the survival and development of macrophages
    Sester, D. P.
    Hines, S. R.
    Ravasi, T.
    Cronau, S. L.
    Sasmono, T.
    Hume, D. A.
    [J]. IMMUNOLOGY, 2007, 120 : 83 - 83
  • [9] PROPERTIES OF RAB5 N-TERMINAL DOMAIN DICTATE PRENYLATION OF C-TERMINAL CYSTEINES
    SANFORD, JC
    PAN, Y
    WESSLINGRESNICK, M
    [J]. MOLECULAR BIOLOGY OF THE CELL, 1995, 6 (01) : 71 - 85
  • [10] Regulation of two JunD Isoforms by Jun N-terminal kinases
    Yazgan, O
    Pfarr, CM
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (33) : 29710 - 29718